Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts.
about
Hepatoblastoma: A Need for Cell Lines and Tissue Banks to Develop Targeted Drug TherapiesThe role of BH3-mimetic drugs in the treatment of pediatric hepatoblastomaPonatinib reduces viability, migration, and functionality of human endothelial cells.Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt/β-Catenin Perspective.A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis.Complete remission of refractory hepatoblastoma after liver transplantation in a child with sorafenib monotherapy: A new hope?
P2860
Q26751517-C5F6FC20-E75D-4FF0-B8B5-C51C765E65ECQ26827928-CB0CEB68-8590-4723-B02E-2E8A661B434DQ33364077-EBE12286-C56B-4476-85D5-C6A2D0017D52Q36185717-4595564A-4451-4B95-8FAC-7768EAA7EE04Q39034663-A2B66717-9006-4368-AD24-86B8272559E7Q46355180-4959083C-E4B9-409C-94BA-D4E8A7B72A72Q47572641-3DF5F36F-56C8-474C-8BC4-47C6214D4390
P2860
Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effect of sorafenib combined w ...... oma cell lines and xenografts.
@ast
Effect of sorafenib combined w ...... oma cell lines and xenografts.
@en
type
label
Effect of sorafenib combined w ...... oma cell lines and xenografts.
@ast
Effect of sorafenib combined w ...... oma cell lines and xenografts.
@en
prefLabel
Effect of sorafenib combined w ...... oma cell lines and xenografts.
@ast
Effect of sorafenib combined w ...... oma cell lines and xenografts.
@en
P2093
P2860
P356
P1476
Effect of sorafenib combined w ...... oma cell lines and xenografts.
@en
P2093
S Armeanu-Ebinger
S Hildenbrand
S W Warmann
V Ellerkamp
P2860
P2888
P304
P356
10.1038/BJC.2012.539
P407
P577
2012-12-20T00:00:00Z